Full Text View
Tabular View
No Study Results Posted
Related Studies
A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas
This study has been completed.
Study NCT00526812   Information provided by Reata Pharmaceuticals, Inc.
First Received: September 7, 2007   Last Updated: December 19, 2008   History of Changes

No Study Results Posted for this Study
About Study Results Reporting
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)